Oxytocin Facilitates Social Learning by Promoting Conformity to Trusted Individuals.

expert interpersonal trust oxytocin – therapeutic use social conformity social learning

Journal

Frontiers in neuroscience
ISSN: 1662-4548
Titre abrégé: Front Neurosci
Pays: Switzerland
ID NLM: 101478481

Informations de publication

Date de publication:
2019
Historique:
received: 18 09 2018
accepted: 21 01 2019
entrez: 22 2 2019
pubmed: 23 2 2019
medline: 23 2 2019
Statut: epublish

Résumé

There is considerable interest in the role of the neuropeptide oxytocin in promoting social cohesion both in terms of promoting specific social bonds and also more generally for increasing our willingness to trust others and/or to conform to their opinions. These latter findings may also be important in the context of a modulatory role for oxytocin in improving the efficacy of behavioral therapy in psychiatric disorders. However, the original landmark studies claiming an important role for oxytocin in enhancing trust in others, primarily using economic game strategies, have been questioned by subsequent meta-analytic approaches or failure to reproduce findings in different contexts. On the other hand, a growing number of studies have consistently reported that oxytocin promotes conformity to the views of groups of in-group individuals. Most recently we have found that oxytocin can increase acceptance of social advice given by individual experts without influencing their perceived trustworthiness

Identifiants

pubmed: 30787864
doi: 10.3389/fnins.2019.00056
pmc: PMC6372972
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

56

Références

Transl Psychiatry. 2015 Jul 14;5:e602
pubmed: 26171983
Psychoneuroendocrinology. 2020 Feb;112:104483
pubmed: 31757429
Psychoneuroendocrinology. 2012 Jan;37(1):162-6
pubmed: 21652150
Psychoneuroendocrinology. 2015 Oct;60:114-9
pubmed: 26143536
PLoS One. 2015 Sep 14;10(9):e0137000
pubmed: 26368396
Psychoneuroendocrinology. 2018 Feb;88:167-172
pubmed: 29304421
Trends Cogn Sci. 2011 Jul;15(7):301-9
pubmed: 21696997
Proc Natl Acad Sci U S A. 2016 Jul 5;113(27):7650-4
pubmed: 27325780
Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4389-94
pubmed: 20160081
Annu Rev Psychol. 2015 Jan 3;66:519-45
pubmed: 25196277
J Pers Soc Psychol. 2011 May;100(5):874-86
pubmed: 21319912
J Pers Disord. 2015 Oct;29(5):575-609
pubmed: 26393477
Front Hum Neurosci. 2013 Sep 25;7:593
pubmed: 24093013
Proc Natl Acad Sci U S A. 2014 Apr 15;111(15):5503-7
pubmed: 24706799
J Psychopharmacol. 2019 Feb;33(2):250-254
pubmed: 30326770
Psychoneuroendocrinology. 2012 Mar;37(3):438-43
pubmed: 21802859
PLoS One. 2015 Jun 01;10(6):e0128047
pubmed: 26030134
Psychiatr Genet. 2014 Apr;24(2):45-51
pubmed: 23921259
PLoS One. 2014 Jan 24;9(1):e87321
pubmed: 24475270
Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):9991-5
pubmed: 20498056
Hum Brain Mapp. 2014 Dec;35(12):6067-76
pubmed: 25094043
Exp Physiol. 2000 Mar;85 Spec No:111S-124S
pubmed: 10795913
Soc Cogn Affect Neurosci. 2015 Jun;10(6):797-800
pubmed: 25193946
Psychoneuroendocrinology. 2017 Sep;83:1-8
pubmed: 28554166
Proc Natl Acad Sci U S A. 2011 Jan 25;108(4):1262-6
pubmed: 21220339
Front Behav Neurosci. 2014 Aug 05;8:266
pubmed: 25140135
Proc Natl Acad Sci U S A. 2017 Aug 29;114(35):9314-9319
pubmed: 28808030
Proc Natl Acad Sci U S A. 2013 Feb 12;110(7):2506-10
pubmed: 23341614
Psychoneuroendocrinology. 2014 Jan;39:74-87
pubmed: 24275006
Science. 2010 Jun 11;328(5984):1408-11
pubmed: 20538951
PLoS One. 2012;7(12):e51095
pubmed: 23227239
Neuropsychopharmacology. 2019 Mar;44(4):749-756
pubmed: 30390065
Nature. 2008 Nov 13;456(7219):245-9
pubmed: 19005555
Front Neurosci. 2018 Jul 31;12:512
pubmed: 30108475
PLoS One. 2009 May 20;4(5):e5535
pubmed: 19461999
Perspect Psychol Sci. 2015 Nov;10(6):772-89
pubmed: 26581735
PLoS One. 2016 Apr 12;11(4):e0153352
pubmed: 27070542
Soc Neurosci. 2013;8(3):189-202
pubmed: 23485131
Psychoneuroendocrinology. 2013 Nov;38(11):2800-4
pubmed: 23768973
J Exp Child Psychol. 2013 Nov;116(3):755-61
pubmed: 23810631
Front Hum Neurosci. 2012 Feb 02;6:4
pubmed: 22347177
Soc Neurosci. 2009;4(4):287-93
pubmed: 18671168
J Neurosci. 2010 Apr 7;30(14):4999-5007
pubmed: 20371820
Psychol Sci. 2014 Jul;25(7):1388-93
pubmed: 24855020
Nature. 2005 Jun 2;435(7042):673-6
pubmed: 15931222
Psychol Sci. 2017 Jun;28(6):751-759
pubmed: 28388303
Patient Educ Couns. 2007 Apr;66(1):29-36
pubmed: 17188453
Nature. 2013 Sep 12;501(7466):179-84
pubmed: 24025838
Horm Behav. 2005 Dec;48(5):522-7
pubmed: 16109416
Int J Neuropsychopharmacol. 2019 Aug 1;22(8):501-512
pubmed: 31152588
Neuropsychologia. 2015 May;71:165-72
pubmed: 25846668
Biol Psychiatry. 2016 Feb 1;79(3):243-50
pubmed: 26049207
Psychol Sci. 2010 Aug;21(8):1072-4
pubmed: 20631321
Horm Behav. 2016 Apr;80:125-131
pubmed: 26862988
Psychother Psychosom. 2019;88(2):125-126
pubmed: 30540987
Autism. 2015 Nov;19(8):1002-9
pubmed: 25520270
Biol Psychiatry. 2016 Feb 1;79(3):194-202
pubmed: 26321019
Hum Factors. 2017 Feb;59(1):116-133
pubmed: 28146673
Psychoneuroendocrinology. 2014 Feb;40:60-8
pubmed: 24485476
Neuron. 2008 May 22;58(4):639-50
pubmed: 18498743
Soc Cogn Affect Neurosci. 2013 Mar;8(3):285-99
pubmed: 22287188
Curr Top Behav Neurosci. 2018;35:321-348
pubmed: 28864976
Psychol Sci. 2013 Dec;24(12):2575-7
pubmed: 24145330
Biol Psychiatry. 2013 Aug 1;74(3):172-9
pubmed: 23419544
JAMA. 2013 Oct 23;310(16):1733-5
pubmed: 24150470
PLoS One. 2010 Jun 16;5(6):e11153
pubmed: 20585395
PLoS Biol. 2011 Jun;9(6):e1001089
pubmed: 21713027
Horm Behav. 2009 Jun;56(1):128-32
pubmed: 19344725
Biol Psychiatry. 2009 Nov 1;66(9):864-70
pubmed: 19640508
Neuropsychologia. 2011 Mar;49(4):602-11
pubmed: 20920512
Soc Cogn Affect Neurosci. 2011 Oct;6(5):556-63
pubmed: 21115541
Hum Brain Mapp. 2015 Jun;36(6):2132-46
pubmed: 25664702
Biol Psychiatry. 2008 Aug 1;64(3):256-8
pubmed: 18343353
Int J Neuropsychopharmacol. 2014 Nov;17(11):1785-92
pubmed: 24916520
Biol Psychol. 2010 Sep;85(1):182-4
pubmed: 20678992
Neuroimage. 2018 Jul 1;174:35-43
pubmed: 29486321
Biol Rev Camb Philos Soc. 2016 May;91(2):390-408
pubmed: 25631363
Psychoneuroendocrinology. 2009 Jul;34(6):917-23
pubmed: 19246160
Neuron. 2011 Mar 24;69(6):1204-15
pubmed: 21435563
Child Dev. 2009 May-Jun;80(3):750-61
pubmed: 19489901
PLoS One. 2009;4(3):e4957
pubmed: 19308261
J Cogn Neurosci. 2007 Sep;19(9):1508-19
pubmed: 17714012
Soc Neurosci. 2013;8(4):305-13
pubmed: 23802121
Cognition. 2008 Sep;108(3):796-803
pubmed: 18721917
Psychol Med. 2017 May;47(7):1311-1322
pubmed: 28091349
Psychoneuroendocrinology. 2013 Dec;38(12):2831-43
pubmed: 23810433
Neuropsychopharmacology. 2015 Mar;40(4):966-73
pubmed: 25308350
PLoS One. 2014 Dec 30;9(12):e116172
pubmed: 25549255
Psychol Sci. 2012;23(11):1288-92
pubmed: 22991128
Front Neuroendocrinol. 2011 Oct;32(4):426-50
pubmed: 21802441
Annu Rev Psychol. 2004;55:591-621
pubmed: 14744228
Biol Psychiatry. 2016 Feb 1;79(3):165-73
pubmed: 25908497
Nature. 1998 Jun 4;393(6684):470-4
pubmed: 9624002
Orphanet J Rare Dis. 2011 Jun 24;6:47
pubmed: 21702900
Neuron. 2013 Oct 16;80(2):312-25
pubmed: 24139036

Auteurs

Lei Xu (L)

The Clinical Hospital of Chengdu Brain Science Institute, MOE Key Laboratory for NeuroInformation, University of Electronic Science and Technology of China, Chengdu, China.

Benjamin Becker (B)

The Clinical Hospital of Chengdu Brain Science Institute, MOE Key Laboratory for NeuroInformation, University of Electronic Science and Technology of China, Chengdu, China.

Keith M Kendrick (KM)

The Clinical Hospital of Chengdu Brain Science Institute, MOE Key Laboratory for NeuroInformation, University of Electronic Science and Technology of China, Chengdu, China.

Classifications MeSH